Abstract:Correction to: Eur Rev Med Pharmacol Sci 2023; 27 (9): 4098-4102. DOI: 10.26355/eurrev_202305_32317-PMID: 37203835-published online on May 15, 2023. After publication, the authors applied a correction in the Funding section. The section has been amended as follows: This study was supported by the research program of Jilin Provincial Science and Technology Department (No. 20190201011J). There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/32317.

Author Correction: Balancing G protein selectivity and efficacy in the adenosine A 2A receptor

Author Correction: Constrained catecholamines gain β 2 AR selectivity through allosteric effects on pocket dynamics

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Author Correction: Structural insights into the activation of metabotropic glutamate receptors

Correction to “A Novel G Protein-Biased and Subtype-Selective Agonist for a G Protein-Coupled Receptor Discovered from Screening Herbal Extracts”

Publisher Correction: Predicting Subtype Selectivity for Adenosine Receptor Ligands with Three-Dimensional Biologically Relevant Spectrum (BRS-3D)

Correction: Corrigendum: CMT2D Neuropathy is Linked to the Neomorphic Binding Activity of Glycyl-Trna Synthetase

Author Correction: BHMT Polymorphism and Susceptibility to PTE in Chinese Patients.

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Author Correction: Structural basis of pH-dependent activation in a CLC transporter

Author Correction: Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy

Author Correction: Pharmacokinetics, mass balance, and metabolism of [ 14 C]vicagrel, a novel irreversible P2Y 12 inhibitor in humans

Author Correction: Chemical genomics with pyrvinium identifies C1orf115 as a regulator of drug efflux

Author Correction: Structure of human GABAB receptor in an inactive state

Correction to "Structure-Activity Relationship of Truncated 2,8-Disubstituted-Adenosine Derivatives as Dual A 2A /A 3 Adenosine Receptor Antagonists and Their Cancer Immunotherapeutic Activity"

Erratum to: The crystal structure of Ac-AChBP in complex with α-conotoxin LvIA reveals the mechanism of its selectivity towards different nAChR subtypes

Author Correction: Synergetic coordination and catecholamine chemistry for catalytic generation of nitric oxide on vascular stents

Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production

Author Correction: NRF2-GPX4/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer cells

Author Correction: Uncovering Pharmacological Mechanisms of Wu-tou Decoction Acting on Rheumatoid Arthritis Through Systems Approaches: Drug-Target Prediction, Network Analysis and Experimental Validation.

Author Correction: Receptor-like cytoplasmic kinases of different subfamilies differentially regulate SOBIR1/BAK1-mediated immune responses in Nicotiana benthamiana